Sinovac Biotech layoffs, on the record
Every job cut, severance charge and restructuring Sinovac Biotech reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from 3,037 to 2,602.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 20-F for 2023 | 3,037 | December 31, 2023 |
| 20-F for 2024 | 2,419 | December 31, 2024 |
| 20-F for 2025 | 2,602 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryThe company restructured its research and development team in Beijing to better use its scientific and personnel resources.
Word for word“In 2008, we restructured our R&D team in Beijing to better utilize our scientific and personnel resources.” 20-F for 2023
Sinovac Biotech has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Sinovac Biotech’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-06-05. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.